Isleworth Healthcare Acquisition Corp. Announces Cancellation of Special Meeting of Shareholders, Redemption of Public Shares and Subsequent Dissolution PR Newswire ST. PETERSBURG, Fla., Aug. 25...
ISLEWORTH AND CYTOVIA TERMINATE MERGER AGREEMENT PR Newswire ST. PETERSBURG, Fla., June 30, 2022 ST. PETERSBURG, Fla., June 30, 2022 /PRNewswire/ -- Isleworth Healthcare Acquisition Corporation...
Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Congress PR Newswire AVENTURA, Fla. and NATICK, Mass., June 10, 2022 Data...
Cytovia Therapeutics to Present In Vivo Multiple Myeloma Data of its CD38-Targeting Flex-NK™ Cell Engager at EHA 2022 Congress PR Newswire AVENTURA, Fla. and NATICK, Mass., May 18, 2022 AVENTURA...
Cytovia Therapeutics to Present at AACR Special Conference on Advances in the Pathogenesis and Molecular Therapies of Liver Cancer PR Newswire AVENTURA, Fla. and NATICK, Mass., May 6, 2022...
Isleworth Healthcare Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report PR Newswire ST. PETERSBURG, Fla., June 3, 2021 ST. PETERSBURG, Fla., June 3, 2021...
Isle of Capri Casinos, Inc. Announces Early Tender Results and Initial Settlement of Cash Tender Offer PR Newswire ST. LOUIS, May 1, 2017 ST. LOUIS, May 1, 2017 /PRNewswire/ -- Isle of Capri...
Eldorado’s Premiere Diversified Regional Gaming Platform Expanded to 19 Gaming Facilities in Ten States Eldorado Resorts, Inc. (NASDAQ: ERI) (“Eldorado,” “ERI,” or “the Company”...
Eldorado Resorts And Isle Of Capri Casinos Announce Preliminary Results Of Elections Made By Isle Stockholders PR Newswire RENO, Nev. and ST. LOUIS, April 27, 2017 RENO, Nev. and ST. LOUIS, April...
Eldorado Resorts, Inc. (NASDAQ: ERI) (“Eldorado,” “ERI,” or “the Company”) and Isle of Capri Casinos, Inc. (NASDAQ: ISLE) (“Isle of Capri” or "Isle") announced today the preliminary results...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約